Austar Lifesciences Ltd. is an investment holding company, which engages in the provision of engineering solutions to pharmaceutical manufacturers and research institutes. The company is headquartered in Shanghai, Shanghai and currently employs 1,446 full-time employees. The company went IPO on 2014-11-07. The firm operates three segments. The Integrated Process and Packaging Equipment & Systems segment mainly includes liquid process systems and powder-solid systems. The Consulting, Digitalization and Construction segment mainly includes design consulting, compliance service systems, as well as cleanroom and automation control systems. The Life Science Equipment and Consumables segment focuses on life science and technology consumables, advanced treatment and advanced bioprocess technologies.
AULSF stock price ended at $0.07 on 星期三, after dropping NaN%
On the latest trading day Feb 19, 2025, the stock price of AULSF fell by NaN%, dropping from $0.07 to $0.07. During the session, the stock saw a volatility of 0.00%, with prices oscillating between a daily low of $0.07 and a high of $0.07. On the latest trading day, the trading volume for AULSF decreased by -- shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 1.0K shares were traded, with a market value of approximately $35.8M.